Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Total article views   HTML views PDF downloads Totals
6,672 Dovepress* 6,198+ 1,347 7,545
PubMed Central* 474 218 692
Totals 6,672 1,565 8,237
*Since 19 September 2018

View citations on PubMed Central and Google Scholar